日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparative Outcomes of Meropenem-Vaborbactam vs. Ceftazidime-Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021

2019-2021年美国成人感染综合征住院患者中美罗培南-伐巴坦与头孢他啶-阿维巴坦疗效比较

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics14010029
Zilberberg, Marya D; Nathanson, Brian H; Redell, Mark A; Sulham, Kate; Shorr, Andrew F
炎症/感染
发表日期：2025
文献求助 收藏

Unfavorable Outcomes and Their Risk Factors in Hospitalized Patients with Staphylococcus aureus Bacteremia in the US: A Multicenter Retrospective Cohort Study, 2020-2022

美国金黄色葡萄球菌菌血症住院患者的不良预后及其危险因素：一项2020-2022年多中心回顾性队列研究

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics14030326
Zilberberg, Marya D; Nathanson, Brian H; Wagenaar, Rolf; Posthumus, Jan; Shorr, Andrew F
发表日期：2025
文献求助 收藏

The Burden of Hospitalization and Rehospitalization Among Patients Hospitalized with Severe Community-Acquired Bacterial Pneumonia in the United States, 2018-2022

2018-2022年美国重症社区获得性细菌性肺炎住院患者的住院和再住院负担

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics14070642
Zilberberg, Marya D; Greenberg, Mike; Curt, Valentin; Shorr, Andrew F
肺炎
微生物学
发表日期：2025
文献求助 收藏

Acinetobacter baumannii Complex Infections: New Treatment Options in the Antibiotic Pipeline

鲍曼不动杆菌复合群感染：抗生素研发管线中的新治疗方案

期刊:Microorganisms
影响因子:4.2
doi:10.3390/microorganisms13020356
Arshad, Noayna; Azzam, Wael; Zilberberg, Marya D; Shorr, Andrew F
炎症/感染
发表日期：2025
文献求助 收藏

Impact of obesity on clinical outcomes in patients treated with ceftobiprole: results from Phase 3 clinical trials

肥胖对接受头孢吡肟治疗的患者临床结局的影响：来自3期临床试验的结果

期刊:Journal of Antimicrobial Chemotherapy
影响因子:3.6
doi:10.1093/jac/dkaf096
Holland, Thomas L; Shorr, Andrew F; Overcash, J Scott; Engelhardt, Marc; Jones, Mark; Ionescu, Daniel; Litherland, Karine; Saulay, Mikael; Fowler, Vance G Jr
肥胖
代谢
发表日期：2025
文献求助 收藏

Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance

头孢吡罗对比头孢曲松±利奈唑胺治疗社区获得性细菌性肺炎（CABP）：一项基于2020年FDA指南的随机3期研究的重新分析

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0326758
Shorr, Andrew F; Jones, Mark E; Friedmann, Silke; Ionescu, Daniel; Saulay, Mikael; Smart, Jennifer I; Engelhardt, Marc
肺炎
微生物学
发表日期：2025
文献求助 收藏

Sustainable solutions to the continuous threat of antimicrobial resistance

应对抗菌素耐药性持续威胁的可持续解决方案

期刊:
影响因子:
doi:10.1093/haschl/qxaf012
Spellberg, Brad; Gilbert, David N; Baym, Michael; Bearman, Gonzalo; Boyles, Tom; Casadevall, Arturo; Forrest, Graeme N; Freling, Sarah; Ghanem, Bassam; Hamilton, Fergus; Luna, Brian; Moore, Jessica; Musher, Daniel M; Nielsen, Travis B; Nori, Priya; Phillips, Matthew C; Pirofski, Liise-Anne; Shorr, Andrew F; Tong, Steven Y C; Lee, Todd C; McDonald, Emily G
发表日期：2025
文献求助 收藏

Bloodstream Infection in the Intensive Care Unit: Evolving Epidemiology and Microbiology

重症监护病房血流感染：流行病学和微生物学的演变

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics13020123
Munro, Carly; Zilberberg, Marya D; Shorr, Andrew F
炎症/感染
流感
微生物学
发表日期：2024
文献求助 收藏

At the Intersection of Critical Care and Infectious Diseases: The Year in Review

重症监护与传染病交叉领域：年度回顾

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines12030562
Sabo, Sarah R; Venkatramanan, Aarthi; Shorr, Andrew F
微生物学
传染病
传染病
发表日期：2024
文献求助 收藏

Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial

接受头孢洛扎/他唑巴坦治疗的机械通气合并院内肺炎和器官衰竭患者的疗效与接受美罗培南治疗患者的疗效比较：一项来自3期随机对照ASPECT-NP试验的亚组分析

期刊:Annals of Intensive Care
影响因子:5.5
doi:10.1186/s13613-022-01084-8
Martin-Loeches, Ignacio; Shorr, Andrew F; Wunderink, Richard G; Kollef, Marin H; Timsit, Jean-François; Yu, Brian; Huntington, Jennifer A; Jensen, Erin; Bruno, Christopher J
肺炎
发表日期：2023
文献求助 收藏